A detailed history of Janus Henderson Group PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 46,018 shares of CRL stock, worth $9.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,018
Previous 42,750 7.64%
Holding current value
$9.17 Million
Previous $8.83 Million 2.65%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $614,253 - $801,607
3,268 Added 7.64%
46,018 $9.07 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $788,616 - $1.03 Million
-3,821 Reduced 8.2%
42,750 $8.83 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $6.71 Million - $9.01 Million
-32,964 Reduced 41.45%
46,571 $12.6 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $1.41 Million - $2.04 Million
8,555 Added 12.05%
79,535 $18.8 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $3.38 Million - $3.78 Million
-17,369 Reduced 19.66%
70,980 $13.9 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $4.72 Million - $5.41 Million
-25,713 Reduced 22.54%
88,349 $18.6 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $8.71 Million - $11.8 Million
45,383 Added 66.08%
114,062 $23 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $13.5 Million - $17.2 Million
68,679 New
68,679 $15 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $124,059 - $170,367
-680 Reduced 14.02%
4,171 $822,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $2 Million - $2.97 Million
-9,822 Reduced 66.94%
4,851 $1.04 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $2.15 Million - $3.05 Million
8,421 Added 134.69%
14,673 $4.17 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $44,625 - $56,982
127 Added 2.07%
6,252 $2.36 Million
Q3 2021

Nov 16, 2021

SELL
$372.64 - $458.3 $4.28 Million - $5.27 Million
-11,489 Reduced 65.23%
6,125 $2.53 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $5.18 Million - $6.55 Million
17,614 New
17,614 $6.52 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $1.23 Million - $2.21 Million
-12,399 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$126.05 - $152.76 $2.64 Million - $3.2 Million
-20,968 Reduced 62.84%
12,399 $1.89 Million
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $4.67 Million - $5.36 Million
-37,309 Reduced 52.79%
33,367 $4.42 Million
Q2 2019

Jul 31, 2019

BUY
$123.4 - $148.55 $2.5 Million - $3.01 Million
20,293 Added 40.28%
70,676 $10 Million
Q1 2019

Apr 30, 2019

SELL
$104.82 - $146.73 $3.22 Million - $4.5 Million
-30,682 Reduced 37.85%
50,383 $7.32 Million
Q4 2018

Feb 06, 2019

BUY
$105.09 - $137.23 $3.21 Million - $4.19 Million
30,565 Added 60.52%
81,065 $9.18 Million
Q3 2018

Nov 09, 2018

BUY
$112.11 - $134.54 $571,761 - $686,154
5,100 Added 11.23%
50,500 $6.79 Million
Q2 2018

Aug 10, 2018

SELL
$102.37 - $117.25 $1.1 Million - $1.25 Million
-10,700 Reduced 19.07%
45,400 $5.1 Million
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $490,950 - $576,000
5,000 Added 9.78%
56,100 $5.99 Million
Q4 2017

Feb 09, 2018

BUY
$100.43 - $118.09 $4.71 Million - $5.54 Million
46,900 Added 1116.67%
51,100 $5.59 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $406,224 - $458,892
4,200
4,200 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.